HLA-DQB1 and cervical cancer in Venezuelan women

Gynecologic Oncology

Volumn 96, Issue 2, 2005, Pages 349-354

  Dao, Dat D ^a   Sierra Torres, Carlos H ^b   Robazetti, Sonia C ^c   De Gomez, Miriam Naranjo ^d   König, Rolf ^c,e   Lema, Carolina ^a   Lester, L James ^a   Au, William W ^e   Tyring, Stephen K ^c,f  

^a HOUSTON ADVANCED RESEARCH CENTER   (United States)

^b UNIVERSIDAD DEL CAUCA   (Colombia)

^c University of Texas Medical Branch School of Medicine   (United States)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f University of Texas Health Science Center at Houston   (United States)

Author keywords

Cervical cancer; Genetic susceptibility; HLA DQB1; Venezuelan women

Indexed keywords

HLA DQB1 ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VENEZUELA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VENEZUELA;

EID: 12344256630     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.10.002     Document Type: Article

References (50)

1. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J. Clin. 49 1 1999 33 64
2. S. Arrossi, R. Sankaranarayanan, and D.M. Parkin Incidence and mortality of cervical cancer in Latin America Salud Publica Mex. 45 Suppl 3 2003 306 314
3. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1 1999 12 19
4. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, and J. Peto Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group J. Natl. Cancer Inst. 87 11 1995 796 802
5. A. Ferenczy, and E. Franco Persistent human papillomavirus infection and cervical neoplasia Lancet Oncol. 3 1 2002 11 16
6. C.M. Wheeler, C.A. Parmenter, W.C. Hunt, T.M. Becker, C.E. Greer, and A. Hildesheim Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center Sex. Transm. Dis. 20 5 1993 286 289
7. M. Clerici, M. Merola, E. Ferrario, D. Trabattoni, M.L. Villa, and B. Stefanon Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection J. Natl. Cancer Inst. 89 3 1997 245 250
8. A. Hildesheim, M.H. Schiffman, T. Tsukui, C.A. Swanson, J. Lucci III, and D.R. Scott Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease Cancer Epidemiol., Biomarkers Prev. 6 10 1997 807 813
9. K.L. Wallin, F. Wiklund, T. Angstrom, F. Bergman, U. Stendahl, and G. Wadell Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer N. Engl. J. Med. 341 22 1999 1633 1638
10. R.J. Apple, H.A. Erlich, W. Klitz, M.M. Manos, T.M. Becker, and C.M. Wheeler HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity Nat. Genet. 6 2 1994 157 162
11. J. Cuzick, G. Terry, L. Ho, J. Monaghan, A. Lopes, and P. Clarkson Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women Br. J. Cancer 82 7 2000 1348 1352
12. M.M. Madeleine, B. Brumback, K.L. Cushing-Haugen, S.M. Schwartz, J.R. Daling, and A.G. Smith Human leukocyte antigen class II and cervical cancer risk: a population-based study J. Infect. Dis. 186 11 2002 1565 1574
13. R.J. Apple, T.M. Becker, C.M. Wheeler, and H.A. Erlich Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma J. Natl. Cancer Inst. 87 6 1995 427 436
14. A. Ferrera, A. Olivo, C. Alaez, W.J. Melchers, and C. Gorodezky HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection Hum. Biol. 71 3 1999 367 379
15. R.J. Neuman, P.C. Huettner, L. Li, E.R. Mardis, B.F. Duffy, and R.K. Wilson Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls Obstet. Gynecol. 95 1 2000 134 140
16. A. Nawa, Y. Nishiyama, T. Kobayashi, Y. Wakahara, T. Okamoto, and F. Kikkawa Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger Cancer 75 2 1995 518 521
17. M. Ghaderi, K.L. Wallin, F. Wiklund, L.N. Zake, G. Hallmans, and P. Lenner Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes Int. J. Cancer 100 6 2002 698 701
18. K. Matsumoto, T. Yasugi, S. Nakagawa, M. Okubo, R. Hirata, and H. Maeda Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer Int. J. Cancer 106 6 2003 919 922
19. A.H. Beskow, and U.B. Gyllensten Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri Int. J. Cancer 101 6 2002 526 531
20. K. Odunsi, and T. Ganesan Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis Int. J. Mol. Med. 8 4 2001 405 412
21. A. Hildesheim, M. Schiffman, D.R. Scott, D. Marti, T. Kissner, and M.E. Sherman Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States Cancer Epidemiol., Biomarkers Prev. 7 11 1998 1035 1041
22. R. Wank, and C. Thomssen High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3 Nature 352 6337 1991 723 725
23. L. Gregoire, W.D. Lawrence, D. Kukuruga, A.B. Eisenbrey, and W.D. Lancaster Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women Int. J. Cancer 57 4 1994 504 507
24. L. Montoya, I. Saiz, G. Rey, F. Vela, and N. Clerici-Larradet Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population Eur. J. Immunogenet. 25 5 1998 329 337
25. P.C. Maciag, N.F. Schlecht, P.S. Souza, E.L. Franco, L.L. Villa, and M.L. Petzl-Erler Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women Cancer Epidemiol., Biomarkers Prev. 9 11 2000 1183 1191
26. S.S. Wang, C.M. Wheeler, A. Hildesheim, M. Schiffman, R. Herrero, and M.C. Bratti Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica J. Infect. Dis. 184 10 2001 1310 1314
27. A.S. Dehaghani, A. Amirzargar, S. Farjadian, and A. Ghaderi HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients Pathol. Oncol. Res. 8 1 2002 58 61
28. C. Vandenvelde, M. De Foor, and D. Van Beers Precision about the association between cervical carcinoma and HLA-DQB1*03 alleles Lancet 342 8870 1993 553
29. K. Odunsi, G. Terry, L. Ho, J. Bell, J. Cuzick, and T.S. Ganesan Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles Int. J. Cancer 67 5 1996 595 602
30. C.B. Sanjeevi, P. Hjelmstrom, G. Hallmans, F. Wiklund, P. Lenner, and T. Angstrom Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women Int. J. Cancer 68 4 1996 409 414
31. R. Wank, J.T. Meulen, J. Luande, H.C. Eberhardt, and M. Pawlita Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles Lancet 341 8854 1993 1215
32. P. Lin, L.A. Koutsky, C.W. Critchlow, R.J. Apple, S.E. Hawes, and J.P. Hughes HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women Cancer Epidemiol., Biomarkers Prev. 10 10 2001 1037 1045
33. Miller BA, Kolonel LN, Bernstein L, Young JJL, Swanson GM, West D, et al. Racial/Ethnic Patterns of Cancer in the United States 1988-1992. Bethesda, MD: National Cancer Institute; 1996. Report No.: NIH Pub. 96-4104
34. O. Olerup, and H. Zetterquist HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation Tissue Antigens 39 5 1992 225 235
35. S. Pizzighella, G. Pisoni, F. Bevilacqua, A. Vaona, and G. Palu Simultaneous polymerase chain reaction detection and restriction typing for the diagnosis of human genital papillomavirus infection J. Virol. Methods 55 2 1995 245 256
36. A.H. Beskow, A.M. Josefsson, and U.B. Gyllensten HLA class II alleles associated with infection by HPV16 in cervical cancer in situ Int. J. Cancer 93 6 2001 817 822
37. M.K. Terris, and D.M. Peehl Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized Urology 50 1 1997 150 156
38. D. Saslow, C.D. Runowicz, D. Solomon, A.B. Moscicki, R.A. Smith, and H.J. Eyre American cancer society guideline for the early detection of cervical neoplasia and cancer CA Cancer J. Clin. 52 6 2002 342 362
39. K. Nasiell, V. Roger, and M. Nasiell Behavior of mild cervical dysplasia during long-term follow-up Obstet. Gynecol. 67 5 1986 665 669
40. J.D. Nash, T.W. Burke, and W.J. Hoskins Biologic course of cervical human papillomavirus infection Obstet. Gynecol. 69 2 1987 160 162
41. J. Cervantes, C. Lema, L. Valentina Hurtado, R. Andrade, L. Hurtado Gomez, and L. Torrico HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women Hum. Immunol. 64 9 2003 890 895
42. C.H. Lema, L.V. Hurtado, D. Segurondo, F. Romero, A. Dulon, and D. Asturizaga Human papillomavirus infection among Bolivian Amazonian women Asian Pac. J. Cancer Prev. 2 2 2001 135 141
43. I. Agurto, A. Bishop, G. Sanchez, Z. Betancourt, and S. Robles Perceived barriers and benefits to cervical cancer screening in Latin America Prev. Med. 39 1 2004 91 98
44. J.L. Hunter Cervical cancer in Iquitos, Peru: local realities to guide prevention planning Cad. Saude Publica 20 1 2004 160 171
45. A. Bingham, A. Bishop, P. Coffey, J. Winkler, J. Bradley, and I. Dzuba Factors affecting utilization of cervical cancer prevention services in low-resource settings Salud Publica Mex. 45 Suppl 3 2003 408 416
46. R.J. Feise Do multiple outcome measures require p-value adjustment? BMC Med. Res. Methodol. 2 1 2002 8
47. K.J. Rothman No adjustments are needed for multiple comparisons Epidemiology 1 1 1990 43 46
48. M. Petz-Erler, C. Gorodezky, and Z. Layrisse HLA: genetic diversity of HLA; functional and medical implication D C Anthropology report for region Latin America: Amerindian and admixed population 1997 EDK Medical Scientific International Publisher Paris, France 337 345
49. N.J. Makhatadze, M.T. Franco, and Z. Layrisse HLA class I and class II allele and haplotype distribution in the Venezuelan population Hum. Immunol. 55 1 1997 53 58
50. H.J. Bontkes, M. van Duin, T.D. de Gruijl, M.F. Duggan-Keen, J.M. Walboomers, and M.J. Stukart HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants Int. J. Cancer 78 2 1998 166 171